Activation of the mGlu7 receptor elicits antidepressant-like effects in mice

Psychopharmacology

Volumn 194, Issue 4, 2007, Pages 555-562

  Palucha, Agnieszka ^a   Klak, Kinga ^a   Branski, Piotr ^a   Van Der Putten, Herman ^b   Flor, Peter J ^b   Pilc, Andrzej ^a,c  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

AMN082; Antidepressant drugs; Forced swim test; Locomotor activity; mGlu7 receptor; Tail suspension test

Indexed keywords

AMN 082; ANTIDEPRESSANT AGENT; IMIPRAMINE; METABOTROPIC RECEPTOR 7; N,N DIBENZYHYDRYL ETHANE 1,2 DIAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG POTENCY; DRUG SELECTIVITY; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BENZHYDRYL COMPOUNDS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENOTYPE; HINDLIMB SUSPENSION; IMIPRAMINE; IMMOBILITY RESPONSE, TONIC; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, METABOTROPIC GLUTAMATE; SPECIES SPECIFICITY; SWIMMING; TIME FACTORS;

EID: 34848860791     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0856-2     Document Type: Article

References (39)

1. Altamura CA, Mauri MC, Ferrara A, Moro AR, D'Andrea G, Zamberlan F (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150:1731-1733
2. Belozertseva IV, Kos T, Popik P, Danysz W, Bespalov AY (2007) Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur Neuropsychopharmacol 17:172-179
3. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G, Popoli M (2005) Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 25:3270-3279
4. Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:889-907
5. Chaki S, Yoshikawa R, Hirota S, Shimazaki T, Maeda M, Kawashima N, Yoshimizu T, Yasuhara A, Sakagami K, Okuyama S, Nakanishi S, Nakazato A (2004) MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity. Neuropharmacology 46:457-467
6. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237
7. Cryan JF, Kelly PH, Neijt HC, Sansig G, Flor PJ, Van Der Putten H (2003) Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur J Neurosci 17:2409-2417
8. Fendt M, Schmid S, Thakker DR, Jacobson LH, Yamamoto R, Mitsukawa K, Maier R, Natt F, Hüsken D, Kelly PH, McAllister KH, Hoyer D, van der Putten H, Cryan JF, Flor PJ (2007) mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol Psychiatry (in press)
9. Golembiowska K, Dziubina A (2000) Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol 52:441-448
10. Holmes A, Murphy DL, Crawley JN (2003) Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 54:953-959
11. Kinoshita A, Shigemoto R, Ohishi H, van der Putten H, Mizuno N (1998) Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J Comp Neurol 393:332-352
12. Klak K, Palucha A, Branski P, Sowa M, Pilc A (2007) Combined administration of PHCCC, a positive allosteric modulator of mGluR4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats. Amino Acids 32:169-172
13. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, Kung HF, Hofer MA, Hen R, Gingrich JA (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54:960-971
14. Mitsukawa K, Yamamoto R, Ofner S, Nozulak J, Pescott O, Lukic S, Stoehr N, Mombereau C, Kuhn R, McAllister KH, van der Putten H, Cryan JF, Flor PJ (2005) A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc Natl Acad Sci U S A 102:18712-18717
15. Mitsukawa K, Mombereau C, Lötscher E, Uzunov DP, van der Putten H, Flor PJ, Cryan JF (2006) Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 31:1112-1122
16. Palucha A (2006) Are compounds acting at metabotropic glutamate receptors the answer to treating depression? Expert Opin Investig Drugs 15:1545-1553
17. Palucha A, Pilc A (2007) Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 115:116-147
18. Palucha A, Tatarczynska E, Branski P, Szewczyk B, Wieronska JM, Klak K, Chojnacka Wojcik E, Nowak G, Pilc A (2004) Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology 46:151-159
19. Palucha A, Branski P, Szewczyk B, Wieronska JM, Klak K, Pilc A (2005) Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pharmacol Biochem Behav 81:901-906
20. Paul IA, Skolnick P (2002) Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003:250-272
21. Pelkey KA, Lavezzari G, Racca C, Roche KW, McBain CJ (2005) mGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition. Neuron 46:89-102
22. Pelkey KA, Yuan X, Lavezzari G, Roche KW, McBain CJ (2006) mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082. Neuropharmacology 52:108-117
23. Pilc A, Klodzinska A, Branski P, Nowak G, Palucha A, Szewczyk B, Tatarczynska E, Chojnacka-Wojcik E, Wieronska JM (2002) Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology 43:181-187
24. Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336
25. Prikhozhan AV, Kovalev GI, Raevskii KS (1990) Effects of antidepressive agents on glutamatergic autoregulatory presynaptic mechanism in the rat cerebral cortex. Bull Exp Biol Med 110:624-626
26. Racz Z, Hamar P (2006) Can siRNA technology provide the tools for gene therapy of the future? Curr Med Chem 13:2299-2307
27. Ritzen A, Mathiesen JM, Thomsen C (2005) Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators. Basic Clin Pharmacol Toxicol 97:202-213
28. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M (2004) Specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705-713
29. Sansig G, Bushell TJ, Clarke VRJ, Rozov A, Burnashev N, Portet C, Gasparini F, Schmutz M, Klebs K, Shigemoto R, Flor PJ, Kuhn R, Knoepfel T, Schroeder M, Hampson DR, Collett VJ, Zhang C, Duvoisin RM, Collingridge GL, van der Putten H (2001) Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7. J Neurosci 21:8734-8745
30. Schoepp DD (2001) Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12-20
31. Stachowicz K, Chojnacka-Wojcik E, Klak K, Pilc A (2006) Anxiolytic-like effects of group III mGlu receptor agonist ACPT-I administered intrahippocampally involve GABA-A signaling. Pharmacol Rep 58:820-826
32. Stachowicz K, Chojnacka-Wojcik E, Klak K, Pilc A (2007) Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Neuropharmacology 52:306-312
33. Steru L, Chermat R, Thierry B, Simon P (1985) Tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370
34. Tatarczynska E, Klodzinska A, Chojnacka-Wojcik E, Palucha A, Gasparini F, Kuhn R, Pilc A (2001) Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br J Pharmacol 132:1423-1430
35. Tatarczynska E, Palucha A, Szewczyk B, Chojnacka-Wojcik E, Wieronska JM, Pilc A (2002) Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4- tricarboxylic acid (ACPT-I) in rats. Pol J Pharmacol 54:707-710
36. Thakker DR, Hoyer D, Schmutz M, Maier R, Natt F, Husken D, Sansig G, van der Putten H, Flor PJ, Cryan JF (2005a) mGluR7 plays a key role in the modulation of anxiety behavior: evidence from mGluR7-knockout mice and siRNA-induced knockdown in the adult mouse brain. Neuropharmacology 49:275 (abstracts)
37. Thakker DR, Natt F, Husken D, van der Putten H, Maier R, Hoyer D, Cryan JF (2005b) siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry 10:782-789
38. Wieronska JM, Szewczyk B, Branski P, Palucha A, Pilc A (2002) Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats. Amino Acids 23:213-216
39. Yoshimizu T, Shimazaki T, Ito A, Chaki S (2006) An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats. Psychopharmacology (Berl) 186:587-593